SUMMARY A partially purified porcine synovial catabolin interleukin 1 (CF) preparation was injected intra-articularly into rabbit stifle (knee) joints. Radiolabelled CF was rapidly cleared from the joint (0.4 h). Repeated injections of CF caused a marked loss of articular cartilage glycosaminoglycan (GAG) and a great increase in synovial fluid GAG. 35So4 uptake was inhibited. Time course experiments after a single injection produced similar loss of GAG from knee cartilages, which was maximal three days after injection. The above changes were significantly less with heat inactivated preparations. Loss of articular cartilage metachromasia was found histologically, and an acute synovitis occurred together with lymphocytic foci and plasma cell infiltration.
Currently the role of locally produced cytokines of the interleukin 1 (IL1) family in the pathogenesis of articular diseases is the subject of much speculation. Catabolin/ILl-like activity is both synthesised and secreted from a variety of connective tissues and cells of human and animal origin maintained in culturel-3; substantial activity has also been shown in a study of human rheumatoid synovial tissue. 4 The action of porcine synovial catabolin/IL1 and porcine leucocyte ILl on cartilage and bone in organ culture has been extensively studied.7 Porcine leucocyte ILl (a and PI forms) has been purified to homogeneity,8 and porcine synovial catabolin/ILl has been substantially purified. It is well recorded that these cytokines can induce living chondrocytes to degrade connective tissue macromolecules in vitro rapidly and extensively. In recent studies it was shown that these porcine cytokines will also inhibit the synthesis of cartilage extracellular macromolecules, e.g., 35SO4 incorporation into proteoglycan and collagen biosynthesis.9 10 These findings may be of some significant importance in the long term action of such messengers, if indeed they do function in vivo.
It seems likely that the porcine leucocyte and synovial cytokines are analogues of human interleukin.11-4 Whatever the degree of interrelationship between the activities of these various Accepted for publication 10 February 1987. Correspondence to Dr D P Page Thomas, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 4RN. messengers, suggestions have been made, based entirely on the in vitro work, that they have a role in cartilage and bone erosions in vivo, in human diseases such as osteoarthritis and rheumatoid arthritis.157 There has been no published work to date on the action of the cytokines on the integrity of articular tissues in vivo.
The work presented below is a preliminary investigation of the action of partially purified synovial catabolin/IL1 (CF) on joint tissues when given intra-articularly. Changes in cartilage catabolism and synthetic activity were found together with inflammatory changes in the synovium. Materials Markwell.19 After the reaction of carrier sodium iodide was added to give a final concentration of 100 mg/ml, and the solution was dialysed for 72 h in two changes of deionised water and a third of physiological saline. All these procedures were performed at 4°C. The final product had an activity of 6 MBq/mg protein. The filter sterilised preparation was then injected intra-articularly into the knees of four rabbits who had been previously sedated with 'Hypnorm' (0-4 ml/kg) (Jannsen Pharmaceuticals, Beerse, Belgium). The rabbits were then positioned rapidly with their knees underneath vertical, lead 527 collimated gamma scintillation probes and the radioactivity measured as previously described. 20 Counting was repeated at intervals up to 24 h.
In the experiment to determine in vivo catabolic action of the cytokine preparation a group of five rabbits was injected with CF and heat inactivated CF (10% of the activity of CF when tested in the organ culture bioassay) into each of their knees in a volume of 0-2 ml. The preparations were randomly allocated to the left and right knees, and the injections were repeated daily for seven days. Two After excision some cartilage specimens were put
Clearance of 131k labelled CF from rabbit knee joints Synovial tissues were fixed in neutral formalin, routinely processed, and stained with haematoxylin and eosin, or toluidine blue. When available articular fibrocartilages were similarly processed and stained for metachromasia by toluidine blue (bone containing specimens being first decalcified with formic acid).
Results
Radiation measurements over the knees declined exponentially with both preparations, and it was thus possible to calculate the clearance rates. Loss of radioactive counts, expressed as a percentage of the initial values for the CF preparation, from a group of four animals are shown in Fig. 1 . The calculated half life for clearance from the joint was 0O38-048 h (the value for bovine serum albumin from the contralateral knees was 1-86-2-84 h).
Because of the very rapid clearance of the CF preparation we initially decided to give daily intraarticular injections for one week in an attempt to discover whether there was any demonstrable in vivo action. The results in Table 1 show that the injection of active CF into the joint space caused substantial loss of GAG from the cartilage. A sixfold increase in the level of GAG was found in the synovial fluid. The 35 o4 incorporation was significantly decreased in both the articular (57%) and patellar cartilage (43%). Heat treatment of the CF greatly reduced its activity in vivo. The joint cartilages not used for biochemical assays were examined histologically and showed marked loss of metachromatic material from the articular cartilages of the fabellae and the fibrocartilaginous area deep to the rectus femoris insertion (Figs 2a-f ). This extensive loss of staining extended throughout both types of cartilage and was not just associated with the very small areas of pannus which were present.
The synovial reaction in the animals treated with CF showed marked synovial proliferation and extensive small roumd cell infiltrates. Polymorphonuclear cells were found in the fluid and could be seen in the subsynovial layer. The heat inactivated preparation showed similar changes, but these were considerably less extensive, and the round cell aggregates were much smaller. The saline injected and the 'needled' controls showed no such changes. Table 2 compares the effect of a single intraarticular injection of CF on the GAG content of different joint cartilages, at various time intervals after injection, with normal knee values from a group of six aninals. The maximal GAG loss occurred at three days. This loss was demonstrable in articular longbone cartilage, sesamoid bone cartilage, and fibrocartilage.
Synovial specimens were taken from the knees and were stained after routine processing by haematoxylin and eosin, toluidine blue, and picromallory methods. At day 1 signs of acute inflammation were present (Fig. 3a) . These was synovial oedema, margination, and migration of polymorphonuclear leucocytes. Some plasma exudation between some of the subsynovial adipocytes was present. A small amount of red cell extravasation also occurred. There were some patchy areas of adipocyte hypertrophy. Some capillaries and postcapillary venules their maximum (Fig. 3b) Nine days after injection a dispersal of the pathological changes had occurred (Fig. 3c) . The only abnormalities present were subsynovial fibrosis, the occasional small round cell focus, scattered small areas of adipocyte hypertrophy, fibrin organisation, and some increase in collagen fibres around small arteries. Polymorphonuclear leucocytes were greatly reduced in number. The effect of a concentration range of CF on the histological changes in the synovium was examined two days F1ig. .5c (log scale) after injection. At the high dose (activity equivalent to 40 ng of ILla protein) these were similar to those described above. Secondly, the cost-in both man hours and materials in preparing a substantial quantity of purified material when it was not known whether or not CF would act on joint tissues in vivo was prohibitive.
The daily injection of the dose used in the first experimental group (Table 1) The correlation between synovial fluid measurement of GAG release and the other parameters of catabolin/IL1 action is encouraging. The application of this method of estimation of synovial fluid GAG has not been used in animals before, and its application to human synovial fluid is being actively pursued.
Although the experiments reported above are essentially preliminary in nature, they do indicate for the first time that a synovial cytokine preparation will cause joint damage in vivo, and this makes determination of its effect worthwhile, using pure materials, dose and time curves, and tissue and cellular localisation with the radiolabelled homogeneous ILla which is now available. Thus it seems likely that much of the theory of the action of these messengers, which has been extrapolated from organ culture work, may be correct. Although it must be emphasised that these animal experiments do not prove that cytokines are partially or totally responsible for arthritic damage in humans, nevertheless their in vivo effects suggest that they may well be implicated in some aspects of pathogenesis.
Further experiments to determine the physiological factors which modify cytokine function in vivo are urgently needed. The application of such knowledge to maintenance of joint tissue function in patients with osteoathritis or rheumatoid arthritis could prove of value.
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